相关实验视频

Updated: May 12, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

心肌梗塞后的心室隔膜断裂:JACC聚焦研讨会 3/5

Roberto J Cubeddu¹, Roberto Lorusso², Daniele Ronco³

¹Division of Cardiology, Section for Structural Heart Disease, Naples Comprehensive Health Rooney Heart Institute, Naples Comprehensive Health Healthcare System, Naples, Florida, USA; Igor Palacios Fellows Foundation, Boston, Massachusetts, USA.

Journal of the American College of Cardiology

|May 8, 2024

概括

心脏病发作后心室隔膜破裂是复杂的,但可以治疗. 新的透导管方法和心脏团队方法改善了心脏性休克患者的治疗结果.

科学领域:

心脏病学心脏病学
心血管外科心血管外科
干预心脏病学干预心脏病学

背景情况:

心室隔膜破裂 (VSR) 是急性心肌梗塞 (MI) 的严重并发症.
虽然血栓解压后治疗的频率较低,但VSR仍然带有高死亡率,通常与耐心心脏性休克有关.
虽然手术修复是有效的,但它具有显著的术后风险.

研究的目的:

审查目前和新兴的管理VSR后MI的战略.
突出了不那么侵袭性跨导管关闭和机械循环支持的作用.
强调多模式成像和心脏团队方法的重要性.

主要方法:

审查关于VSR管理的当前文献.
讨论过导管关闭技术和穿皮的机械循环支持.
强调多模式成像用于解剖评估.
探索心脏团队治疗时间和策略的方法.
考虑先进的选择,如心脏移植和息治疗.

主要成果:

透导管关闭为手术提供了一个不那么侵入性的替代方案,特别是在心脏性休克中.
穿皮式机械循环支持有助于稳定患者并保持器官功能.
多模式成像指导选择最佳修复策略.
心脏团队方法优化了治疗时间和患者选择各种干预措施.
对于特定的患者群体,考虑推迟治疗和息护理.

结论:

过导管关闭和机械循环支持在VSR管理方面取得了重大进展.
多学科的心脏团队方法对于个性化的VSR治疗至关重要.
综合性成像和考虑先进/缓性选择可以改善患者的治疗结果.

关键词:

心脏发生的冲击是心脏发生的冲击.心脏移植心脏移植手术心肌梗塞的心脏病发作通过皮肤的关闭.腹腔隔膜破裂腹腔隔膜破裂

更多相关视频

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure

Published on: December 2, 2014

Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice

Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice

Published on: February 1, 2022

相关概念视频

Mitral Regurgitation I: Introduction

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...

Mitral Regurgitation III: Medical Management

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...

Aortic Regurgitation I: Introduction

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...

Aortic Regurgitation III: Medical Management

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...